뉴로피드백 2.0: AI 기반 교차 종 뇌 최적화

Neurofeedback is a brain training technique used for ADHD, anxiety/PTSD, etc. However, existing devices only measure the user's brainwaves and provide uniform feedback, resulting in a lack of personalization and limited effectiveness.

Additionally, it is difficult for users to know which training is effective, leading to many trials and errors, and some wearables provide ambiguous data interpretations, causing confusion for end-users.

Meanwhile, anxiety/stress issues in pets are also emerging, but there are no effective real-time monitoring/training tools to manage them.

Both humans and animals experience stress and concentration problems, but comprehensive approaches have been difficult due to existing solutions being separated.

The Neurofeedback 2.0 platform simultaneously collects and analyzes brainwaves from humans and animals through the BrainBit EEG headband for humans and the Callibri EEG band for animals.

Using an AI graph DB and a federated learning-based knowledge base, it interprets EEG, electromyography (EMG), and heart rate variability (HRV) biomarkers in real-time and automatically presents optimized neurofeedback protocols for each user.

For example, by matching a human's relaxation training protocol with the brainwave patterns of their pet dog, it provides cross-species insights, such as conducting calming training for the dog and concentration training for the human simultaneously.

Low-latency processing is possible on edge devices, and cloud AIExplainable AI (XAI)enhances reliability by presenting the reasons for training recommendations.

By applying a real-time brainwave sensing-feedback loop to both humans and animals, it enables comprehensive brain training that was not possible before, such as simultaneously achieving separation anxiety training for dogs and stress relief for users.

Brain training clinics, psychotherapy centers, and neuroscience research institutes are expected to adopt this system for treatment assistance or clinical research (B2B).

For example, an ADHD treatment clinic may use it in a program to calm children and their pets together, or a sports psychology training center may use it to coordinate the brainwaves of athletes and their trained dogs.

Among individual consumers (B2C), meditation enthusiasts or pet trainers may be interested, but considering the equipment price range and expertise required, it is likely to be positioned as professional equipment.

In addition, university and corporate research institutes can use it for human-animal interaction research, and veterinarians or animal behavior experts can consider a B2B2C model to utilize it as a customer service.

There is potential at the intersection of the two huge markets of mental healthcare and pet care.

However, since the unfamiliar area of animal EEG needs to be pioneeredthe initial market may be a niche.the initial market may be a niche.

If medical certifications such as FDA are obtained, it can enter the medical market as an aid for ADHD/anxiety treatment, or it can be positioned as a health/wellness device to target a relatively less regulated market.

Geographically, it will first spread to developed countries with advanced pet culture.

Technically, as the amount of collected data increases, AI will create more sophisticated protocols, which will improve service quality and lead to market expansion.

In addition, if other biosignals (e.g., hormones, skin conductance) are integrated, it can be expanded into a broader biofeedback platform.

Selected as an Innovation Award Honoree in the AI category at CES 2026,it has garnered attention as "an original attempt to expand the boundaries of AI and neurofeedback."it has garnered attention as "an original attempt to expand the boundaries of AI and neurofeedback."

There has been much positive feedback on the combination of non-invasive EEG headset technology and real-time AI coaching, and in particular, there have been surprised reactions to the idea of encompassing both humans and animals.

However, market expectations are somewhat mixed. Some view neurofeedback itself as a niche treatment, questioning whether the application is too narrow, while others believe it is undervalued as a new market creation that combines wellness trends and the pet care market.

In terms of technological completeness, the HW reliability has been verified as BrainBit's existing product (EEG headband) is already on the market, but the clinical validity of the AI protocol needs to be proven with additional data in the future.

In summary, the concept is innovative, but there is uncertainty in market formation.